Refractive Surgery and Optive Compatibility Study

To assess the compatibility of Optive with refractive surgery (PRK and LASIK) post-operatively.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dry Eye Syndromes Eye Diseases Lacrimal Apparatus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

TLC

Fullerton, California, 92831, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Men and women 18 and over
Patients undergoing refractive surgery

Exclusion criteria

Concurrent ocular conditions or pathology that could affect patient's ability to complete study
Concurrent use of topical medications other than study medications
Use of systemic medications with ocular drying sequelae:

Antihistamines
Decongestants
Antispasmotics
Antidepressants

Treatment and study plan

Optive

Drug

Optive 30ml- (in the eye) Instill one in each eye twice daily starting one week after surgery

Primary outcomes

Assess compatibility

Time frame: 8 months

Secondary outcomes

comfort

Time frame: 8 months

Sponsors and collaborators

Lead sponsor

Innovative Medical

Industry

Registry information

Important dates

Study start: 2007
Primary completion: 2008
Study completion: 2008
First posted: May 4, 2007
Registry last updated: Apr 17, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed